Pfizer Quits Bickering Over Mirapex Bellwether Trials
After many months of wrangling over the bellwether trial process, the two sides in the multidistrict litigation over Pfizer Inc.'s Mirapex have agreed on the first three cases to go before...To view the full article, register now.
Already a subscriber? Click here to view full article